Edap Tms (NASDAQ:EDAP) Rating Lowered to “Sell” at StockNews.com

Edap Tms (NASDAQ:EDAP) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a report released on Monday.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a research note on Thursday, August 29th.

Edap Tms Trading Down 3.7 %

Shares of EDAP traded down $0.09 during trading hours on Monday, reaching $2.36. 78,779 shares of the company traded hands, compared to its average volume of 60,190. The firm has a market cap of $87.57 million, a price-to-earnings ratio of -3.63 and a beta of 0.38. Edap Tms has a 12-month low of $2.27 and a 12-month high of $8.50. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The stock’s fifty day moving average price is $2.80 and its 200 day moving average price is $4.31.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The business had revenue of $16.97 million during the quarter, compared to analyst estimates of $17.16 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. Sell-side analysts forecast that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

Institutional investors have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new position in Edap Tms during the first quarter worth $82,000. Commonwealth Equity Services LLC lifted its position in Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after buying an additional 4,000 shares during the period. Redhawk Wealth Advisors Inc. acquired a new stake in Edap Tms during the third quarter worth about $36,000. BNP Paribas Financial Markets increased its stake in Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares during the last quarter. Finally, Orion Capital Management LLC increased its stake in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares during the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.